Medicare Enrolled
Dr. Donald Cross, M.D.
Cardiovascular Disease · Waco, TX
Practice pattern: Electrophysiology & Remote— Practice combining electrophysiology and remote services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cross from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cross? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cross
Dr. Donald Cross is a cardiovascular disease in Waco, TX, with 20 years in practice. Based on federal Medicare data, Dr. Cross performed 8,272 Medicare services across 5,967 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cross received a total of $25,939 from 31 pharmaceutical and/or device companies across 208 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cross is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 5% volume in TX$ $25,939 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,272
Medicare services
Top 5% in TX for cardiovascular disease
5,967
Unique beneficiaries
$98
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~414 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,128 | $87 | $140 |
| Remote pacemaker/defibrillator monitoring, 90 days | 977 | $15 | $101 |
| Remote pacemaker monitoring, 90 days | 949 | $20 | $105 |
| Regadenoson injection (Lexiscan) for heart stress test | 888 | $43 | $70 |
| Electrocardiogram (EKG), 12-lead | 622 | $10 | $140 |
| Programming of dual lead pacemaker system | 354 | $53 | $181 |
| Ultrasound of both sides of head and neck blood flow | 341 | $129 | $557 |
| Chronic care management, first 20 min/month | 322 | $48 | $114 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 265 | $52 | $593 |
| Remote patient monitoring device, 30 days | 222 | $37 | $183 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 212 | $255 | $344 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 165 | $18 | $92 |
| Hospital follow-up visit, moderate complexity | 161 | $62 | $142 |
| Ultrasound study of arm and leg arteries | 152 | $48 | $400 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 127 | $1,826 | $6,839 |
| Chronic care management, additional 20 min/month | 127 | $37 | $101 |
| Nuclear medicine study of heart muscle blood flow by pet | 124 | $139 | $520 |
| Echocardiogram, transthoracic | 107 | $137 | $1,558 |
| New patient office visit (45-59 min) | 103 | $118 | $225 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 87 | $131 | $564 |
| EKG interpretation and report | 86 | $6 | $52 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 80 | $1,067 | $2,718 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 61 | $127 | $496 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 55 | $317 | $2,975 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 50 | $56 | $79 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 46 | $10 | $76 |
| Ultrasound of leg arteries or artery grafts | 43 | $167 | $553 |
| Programming of single lead pacemaker system | 41 | $45 | $150 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 38 | $25 | $201 |
| Initial hospital admission, high complexity | 38 | $136 | $349 |
| Ultrasound of one leg arteries or artery grafts | 36 | $93 | $373 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 35 | $93 | $206 |
| Programming of multiple lead pacemaker system | 33 | $59 | $213 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 32 | $181 | $658 |
| Cardiac catheterization | 28 | $165 | $4,269 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 26 | $83 | $349 |
| Coronary stent placement | 23 | $407 | $4,602 |
| Nuclear medicine study of heart muscle at rest and with stress and spect | 19 | $50 | $642 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 16 | $13 | $57 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 14 | $19 | $204 |
| Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | 14 | $41 | $181 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 13 | $165 | $4,977 |
| Ultrasound of heart, follow-up | 12 | $19 | $156 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
31.7% high complexity
27.6% medium
40.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$25,939
Total received (2018-2024)
Avg $3,706/year across 7 years
Top 16% in TX for cardiovascular disease
31
Companies
208
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,927 (53.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$7,989 (30.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,022 (15.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,427
2023$951
2022$2,863
2021$2,187
2020$3,661
2019$8,174
2018$4,676
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Philips Electronics North America Corporation
$12,012
ABIOMED
$1,727
Penumbra, Inc.
$1,455
Terumo Medical Corporation
$1,311
Boston Scientific Corporation
$1,193
AstraZeneca Pharmaceuticals LP
$1,174
BIOTRONIK INC.
$1,135
Medtronic, Inc.
$1,015
Abbott Laboratories
$789
Cardiovascular Systems Inc.
$651
Medtronic Vascular, Inc.
$634
BOSTON SCIENTIFIC CORPORATION
$559
Shockwave Medical, Inc
$396
Inari Medical, Inc.
$258
Novartis Pharmaceuticals Corporation
$241
ShockWave Medical, Inc
$234
Janssen Pharmaceuticals, Inc
$213
Cardinal Health 200, LLC
$161
Impulse Dynamics (USA) Inc.
$131
Bayer Healthcare Pharmaceuticals Inc.
$116
Amarin Pharma Inc.
$107
Bayer HealthCare Pharmaceuticals Inc.
$96
PFIZER INC.
$83
Actelion Pharmaceuticals US, Inc.
$76
Novo Nordisk Inc
$37
E.R. Squibb & Sons, L.L.C.
$36
Kiniksa Pharmaceuticals International, plc
$29
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
Amgen Inc.
$17
Kiniksa Pharmaceuticals, Ltd.
$15
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$15
Top 3 companies account for 58.6% of total payments
Associated products mentioned in payments ›
(6554) Peripheral Vascular Undivided · (6571) Eagle Eye · (9520) IGT Devices Undivided · ASSURITY · AVVIGO Guidance System · Allure Quadra RF CRT Pacemaker · Arcalyst · Astron; Pulsar; AstronPulsar · CAMZYOS · CARDIOMEMS · CONFIRM RX · COREVALVE EVOLUT R · Clinical Trial Product · Confirm Rx · CoreValve Evolut · Corlanor · Diamondback Peripheral · EMBLEM MRI S-ICD · ENSITE PRECISION · ENTRESTO · Edora 8 DR-T · FARXIGA · FLOWTRIEVER CATHETER · GENERAL BRADY · GENERAL THERAPIES · GENERAL STENTS · GENERAL - BRADY · GENERAL STENTS · GLIDESHEATH SLENDER · GLIDEWIRE · General - Therapies · General - Vascular Access · HawkOne · Heartrail · IGT D Coronary · IGT D Peripheral · IGT_D Peripheral · IGT_D Systems · IN.PACT Admiral · INTELLIS ADAPTIVESTIM · IVUS Systems · Impella · Indigo · Indigo System · JARDIANCE · Kerendia · LATITUDE Communicator Power Supply · LEQVIO · LINQ II · LUX DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · MynxGrip Vascular Closure Device · ONYX FRONTIER · Optimizer · Orsiro · Ozempic · Passeo-18 · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · PressureWire FFR · QT Vascular Chocolate PTA Balloon · R2P MISAGO · RESOLUTE ONYX · RESONATE · ROTABLATOR · Resolute · S · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SQ-RX PULSE GENERATOR · SYMPLICITY G3 · Spectranetics Undiv · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · UPTRAVI · VALITUDE CRT-P · Vascepa · Vascular Lithotripsy · WATCHMAN · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (54%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $314 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
18
Per 100K population
6.8
County median income
$63,888
Nearest hospital
ASCENSION PROVIDENCE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Cross is a electrophysiology & remote specialist, with above-average Medicare volume (top 5% in TX), and high industry engagement (low-engagement, top 16%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Cross experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Cross performed 1,128 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cross receive payments from pharmaceutical companies?
Yes. Dr. Cross received a total of $25,939 from 31 companies across 208 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cross's costs compare to other cardiovascular diseases in Waco?
Dr. Cross's average Medicare payment per service is $98. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cross) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Waco
Browse cardiovascular diseases in Waco ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Philips Electronics North America Corporation Payments to Doctors
See all physicians who received payments from Philips Electronics North America Corporation.
By company
ABIOMED Payments to Doctors
See all physicians who received payments from ABIOMED.
By company
Penumbra, Inc. Payments to Doctors
See all physicians who received payments from Penumbra, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology